Therapy News and Research

RSS

Using AI to determine which lung cancer patients will benefit from immunotherapy

Scientists from the Case Western Reserve University digital imaging lab, already pioneering the use of Artificial Intelligence to predict whether chemotherapy will be successful, can now determine which lung-cancer patients will benefit from expensive immunotherapy.

23 Nov 2019

FDA approves Ohio State-developed drug to treat patients with CLL and SCL

On Nov. 21, 2019, the U.S. Food and Drug Administration approved the use of the drug acalabrutinib for first-line therapy in chronic lymphocytic leukemia and small cell lymphoma.

22 Nov 2019

Virtual reality clinic could make it easier for stroke survivors to attend therapy sessions

Researchers have created a virtual reality clinic to make it easier for stroke survivors to attend their physical and occupational therapy sessions.

22 Nov 2019

Combination therapy improves survival in patients with hepatocellular carcinoma

Combination therapy with the PD-L1 inhibitor atezolizumab and the VEGF inhibitor bevacizumab significantly improves overall survival and progression-free survival in patients with unresectable hepatocellular carcinoma compared to standard of care, showed results from a phase 3 study reported at the ESMO Asia 2019 Congress.

22 Nov 2019

University of Sheffield receives Queen's Anniversary Prize for innovation in neuroscience

Neuroscience research at the University of Sheffield has been recognized by Her Majesty The Queen for delivering real benefits in improving patient outcomes for people living with some of the most devastating neurodegenerative diseases.

22 Nov 2019

Using behavioral sciences to promote oral health

2019 marks the Centennial of the Journal of Dental Research. Over the last century the JDR has been dedicated to the dissemination of new knowledge and information on all sciences relevant to dentistry and to the oral cavity and associated structures in health and disease.

22 Nov 2019

Scientists investigate the dynamics of molecular changes in gliomas

Until relatively recently, cancer was viewed as a single disease with sub-types based on where in the body it arose.

22 Nov 2019

Researchers discover molecular underpinnings of Alexander disease

Scientists have known that genetic mutations leading to the production of a defective protein called GFAP cause Alexander disease (AxD), a debilitating neurodegenerative condition that can present during infancy, adolescence, or adulthood.

21 Nov 2019

Excellent mental health for 68% of Indigenous people living off reserve in Canada

Two-thirds (68%) of Indigenous people living off reserve in Canada have excellent mental health, according to a nationally representative study conducted by the University of Toronto and Algoma University.

21 Nov 2019

Extra DNA scooped up alongside cancer-causing genes helps drive tumor growth

One of the ways a cancer-causing gene works up enough power to turn a normal cell into a cancer cell is by copying itself over and over, like a Xerox machine.

21 Nov 2019

CU Anschutz to train students to prescribe buprenorphine products for opioid use disorder

As the nation struggles with a persistent epidemic of opioid addiction, the University of Colorado Anschutz Medical Campus is taking a critical step that will allow its graduates to better treat patients and save lives.

21 Nov 2019

UIC receives $1.8 million CDC grant for new breast cancer survivorship research

With $1.8 million in funding from the U.S. Centers for Disease Control and Prevention, the University of Illinois at Chicago will help young breast cancer survivors navigate post-treatment care and survival.

21 Nov 2019

Texas Heart Institute student receives prestigious Perfusion Without Borders scholarship

Texas Heart Institute School of Perfusion Technology student, Leslie Gonzalez was awarded the prestigious Perfusion Without Borders scholarship and will travel with the Novick Cardiac Alliance to Medellin, Colombia in February of 2020.

21 Nov 2019

Study could help predict resistance to pancreatic cancer treatments

A study from the University of North Carolina Lineberger Comprehensive Cancer Center could help predict resistance to treatments for pancreatic cancer, one of the deadliest cancer types.

21 Nov 2019

Kessler Foundation to study use of minimally invasive treatment for meniscal tears

Kessler Foundation received a $590,000 award from The Geneva Foundation for a three-year study of the use of a an experimental minimally invasive treatment for meniscal tears--the injection of autologous micro-fragmented adipose tissue into the knee joint.

21 Nov 2019

Graphene-based nanoplatforms for synergistic tumor therapy and bio-imaging

In a paper to be published in the forthcoming issue in NANO, researchers from Harbin Institute of Technology, China have systematically discussed the recent progresses, current challenges and future perspectives of smart graphene-based nanoplatforms for synergistic tumor therapy and bio-imaging.

21 Nov 2019

Ultrasound treatment could be safe and effective option for people with essential tremor

People with tremors in their hands, head or voice may find some relief for up to three years from a treatment using ultrasound waves to destroy the area of the brain causing the tremor, according to a study published in the November 20, 2019, online issue of Neurology, the medical journal of the American Academy of Neurology.

21 Nov 2019

Nationwide survey highlights patients’ perspectives about cancer treatment experiences

One in three adults treated for cancer may experience side effects from treatment they wish they had known more about, according to a new survey published today in the Journal of Oncology Practice.

21 Nov 2019

Inflammatory processes drive progression of neurodegenerative brain diseases

Inflammation drives the progression of neurodegenerative brain diseases and plays a major role in the accumulation of tau proteins within neurons.

20 Nov 2019

BrainStorm publishes NurOwn ALS Phase 2 randomized clinical trial results in Neurology

BrainStorm Cell Therapeutics Inc., a leader in the development of innovative autologous cellular therapies for highly debilitating neurodegenerative diseases, today announced publication of "NurOwn Phase 2 Randomized Clinical Trial in ALS: Safety, Clinical and BioMarker Results," in the international, peer-reviewed journal Neurology.

20 Nov 2019

Therapy News and Research

Using AI to determine which lung cancer patients will benefit from immunotherapy

FDA approves Ohio State-developed drug to treat patients with CLL and SCL

Virtual reality clinic could make it easier for stroke survivors to attend therapy sessions

Combination therapy improves survival in patients with hepatocellular carcinoma

University of Sheffield receives Queen's Anniversary Prize for innovation in neuroscience

Using behavioral sciences to promote oral health

Scientists investigate the dynamics of molecular changes in gliomas

Researchers discover molecular underpinnings of Alexander disease

Excellent mental health for 68% of Indigenous people living off reserve in Canada

Extra DNA scooped up alongside cancer-causing genes helps drive tumor growth

CU Anschutz to train students to prescribe buprenorphine products for opioid use disorder

UIC receives $1.8 million CDC grant for new breast cancer survivorship research

Texas Heart Institute student receives prestigious Perfusion Without Borders scholarship

Study could help predict resistance to pancreatic cancer treatments

Kessler Foundation to study use of minimally invasive treatment for meniscal tears

Graphene-based nanoplatforms for synergistic tumor therapy and bio-imaging

Ultrasound treatment could be safe and effective option for people with essential tremor

Nationwide survey highlights patients’ perspectives about cancer treatment experiences

Inflammatory processes drive progression of neurodegenerative brain diseases

BrainStorm publishes NurOwn ALS Phase 2 randomized clinical trial results in Neurology

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News